Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPodiatryAetna bunionectomy Coverage Policy Update | OpenPa…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentAetnaPolicy 0629

    Bunionectomy

    Customize your policy alerts

    Sign up for Aetna Policy 0629 alerts

    Get alerted when Policy 0629 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Clinical policy for medical necessity and coverage criteria for bunionectomy procedures (simple soft-tissue bunionectomy, bony correction bunionectomy, cheilectomy, arthrodesis, bunionette correction) and related interventions, affecting Aetna members and their providers.

    Policy Summary
    PayerAetna
    PolicyBunionectomy
    Policy CodePolicy 0629
    Change TypeNo material changes
    Effective DateJun 28, 2002
    Last ReviewSep 12, 2023
    Next Review DateJul 11, 2024
    Key ActionDocument persistent pain and at least a 6-month trial of conservative therapies and weight-bearing radiographs showing required HVA/IMA thresholds when seeking coverage.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    6 monthsconservative treatment prior to surgery
    HVA ≥30°; IMA ≥12°bony correction radiographic threshold
    HVA ≥15°simple bunionectomy threshold
    IMA ≥10°; MTP ≥16°bunionette radiographic thresholds
    09/12/2023last review
    0629policy id

    Coverage Criteria for Bunionectomy and Related Procedures

    Simple Bunionectomy (medically necessary)

    Covered when ONE of the following is met:

    Simple Bunionectomy Criteria: 1) Clinical symptoms with history of conservative management: documentation of persistent pain and difficulty walking despite at least six months of conservative treatment directed by a healthcare professional (including alternative/modified footwear; corticosteroid injections; debridement of hyperkeratotic lesions; foot orthotics (generally contractually excluded); oral analgesics/NSAIDs; protective cushions/pads); AND radiographic confirmation of a hallux valgus angle (HVA) >= 15 degrees with no degenerative changes at the first MTP joint; AND documentation of skeletal maturity. OR 2) Member with diabetes who has an ulcer and/or infection stemming solely from the bunion.HVA >=15°; >=6 months conservative care

    Radiographic confirmation must include weight-bearing AP and lateral views as documented in the radiology report.

    Bony Correction Bunionectomy (medically necessary)

    Covered when ALL of the following are met:

    Policy Summary
    PayerAetna
    PolicyBunionectomy
    Policy CodePolicy 0629
    Change TypeNo material changes
    Effective DateJun 28, 2002
    Last ReviewSep 12, 2023
    Next Review DateJul 11, 2024
    Key ActionDocument persistent pain and at least a 6-month trial of conservative therapies and weight-bearing radiographs showing required HVA/IMA thresholds when seeking coverage.
    SourceLink
    On This Page
    Coverage Criteria for Bunionectomy and Related ProceduresCPT, HCPCS and Diagnosis CodesDocumentation, Prior Authorization, and Operational GuidanceBackground and Clinical ContextDefinitions and Measurement ThresholdsPolicy Dates and Revision History
    Bony Correction Core Criteria:
    1) Skeletally mature individual (or >=18 years); AND 2) Persistent pain and symptoms over the medial bony eminence or calluses making walking difficult despite at least 6 months of conservative treatment under direction of a healthcare professional (protective cushions/pads; shoe inserts generally contractually excluded; corticosteroid injections; debridement of hyperkeratotic lesions; oral analgesics/NSAIDs; alternative/modified footwear as specified); AND 3) Weight-bearing radiograph demonstrating BOTH HVA >= 30 degrees AND intermetatarsal angle (IMA) >= 12 degrees; AND 4) Documentation of skeletal maturity; AND 5) One or more of the following: neuroma secondary to the bunion; dorsiflexed/overriding second toe (crossover toe); limited or painful ROM at first MTP; painful prominence of dorsiflexed second toe due to pressure; ulceration caused by the bunion; recurrent bursitis; OR radiographic evidence of osteoarthritis (cysts in metatarsal head OR loss of cartilage space OR mild-to-moderate bony proliferative pathology); OR need to relieve a predisposing factor (e.g., Achilles tendon contracture).
    HVA >=30° AND IMA >=12°; >=6 months conservative care

    Radiographic confirmation must include weight-bearing AP and lateral views; bilateral simultaneous bunionectomy generally not medically necessary unless extenuating circumstances.

    Surgical Correction of First MTP Joint (including hallux rigidus)

    Covered when ALL of the following are met:

    MTP Joint Surgery Criteria: 1) Radiographic confirmation of osteoarthritis of the first MTP joint evidenced by any of: cysts in the metatarsal head; loss of cartilage space between the bones; or mild-to-moderate bony proliferative pathology; AND 2) Documentation of persistent pain and difficulty walking despite at least six months of conservative treatment under the direction of a healthcare professional (alternative/modified footwear; corticosteroid injections; debridement of hyperkeratotic lesions; foot orthotics generally excluded; oral analgesics/NSAIDs; protective cushions/pads); AND 3) Documentation of skeletal maturity.Radiographic OA findings; >=6 months conservative care

    Applies to procedures for hallux rigidus including arthrodesis, cheilectomy, or Keller procedure when criteria met.

    Bunionette Correction

    Covered when ALL of the following are met:

    Bunionette Criteria: 1) Radiographic confirmation of IMA >= 10 degrees AND MTP angle >= 16 degrees; AND 2) Documentation of persistent pain and difficulty walking despite at least six months of conservative treatment under the direction of a healthcare professional (alternative/modified footwear; corticosteroid injections; debridement of hyperkeratotic lesions; foot orthotics generally excluded; oral analgesics/NSAIDs; protective cushions/pads); AND 3) Documentation of skeletal maturity.IMA >=10° and MTP angle >=16°; >=6 months conservative care

    Radiographic confirmation must include weight-bearing AP and lateral views.

    Cheilectomy

    Covered when ONE of the following is met:

    Cheilectomy Criteria: 1) Painful bony spurs in earlier stages of an arthritic first MTP joint; OR 2) Painful hallux rigidus that meets the radiographic and clinical criteria for surgical correction of the MTP joint (see MTP Joint Surgery Criteria).Meets MTP OA criteria or painful bony spurs

    Cheilectomy is appropriate for earlier-stage arthritic disease; not appropriate for advanced degenerative joint changes.

    Arthrodesis (fusion) of the foot

    Covered when ANY of the listed conditions are present:

    Arthrodesis Indications: Hallux valgus deformity when the second toe is absent; OR advanced hallux valgus (IMA >20 degrees or HVA >40 degrees); OR failed bony correction bunionectomy (e.g., Keller procedure); OR failed cheilectomy; OR painful symptoms secondary to hallux valgus with advanced degenerative joint disease; OR painful symptoms secondary to hallux rigidus with advanced degenerative joint disease meeting MTP joint criteria; OR severely subluxated or dislocated MTP joints.IMA >20° or HVA >40° for advanced deformity

    Fusion (arthrodesis) is the procedure of choice for advanced degenerative disease, severe deformity, failed prior surgery, or absent second toe stabilization.

    Coverage criteria for bunionectomy procedures

    Surgery is considered when ALL of the following are met:

    General surgical indication: Patient has pain and/or difficulty walking despite accepted conservative treatments (accommodative shoes, pads, orthotics, NSAIDs).

    Conservative measures should be documented for at least six months.

    Radiographic severity: Angular deformities corresponding to moderate to severe stage (examples provided): IMA >=12 degrees for moderate; IMA >16 degrees for severe; HVA >30-35 degrees often associated with pronation; HVA >40 degrees considered severe.See radiographic thresholds (IMA/HVA)

    Reference Campbell's staging for examples of mild/moderate/severe.

    Complicating indications: Presence of complications directly related to the bunion (e.g., severely subluxated or dislocated MTP joints, advanced degenerative joint disease, inability to wear shoes, painful callus or recurrent bursitis) supports need for surgical correction.

    Also consider arthrodesis when advanced degenerative changes or failed prior procedures are present.

    Coverage criteria for hallux rigidus and arthritic indications

    For hallux rigidus / advanced degenerative disease, covered procedures when ALL apply:

    Arthrodesis indication: Advanced degenerative joint disease, advanced hallux valgus (IMA >20 degrees or HVA >40 degrees), severely subluxated or dislocated MTP joints, or failed prior hallux valgus surgery — arthrodesis (fusion) is the procedure of choice in these settings.

    Fusion preferred for advanced degenerative disease or severe deformity.

    Cheilectomy vs alternatives: Cheilectomy may be used in earlier stages for painful bone spurs and is not appropriate for advanced degenerative joint changes; consider alternative procedures (e.g., decompression osteotomy) based on disease stage and revision risk evidence.

    Procedure selection should be justified with clinical and radiographic documentation.

    Aetna considers the following interventions experimental and investigational because effectiveness has not been established: the use of allograft in bunion repair and continuous wound infiltration with local anesthetics after hallux valgus surgery. (These are listed as not established for other indications in the policy's experimental and investigational section.)

    The policy also notes that CPT and ICD code lists include codes that are not covered in certain clinical scenarios (for example, procedures billed when severe vascular insufficiency, gangrene, non-ambulatory status, or skin ulceration not caused by the bunion are present).

    Most bunions are asymptomatic and do not require surgery. The policy emphasizes prevention and nonoperative management first — wide, well‑fitting shoes, low heels, protective pads, shoe modification, and other conservative measures — and indicates that surgery is reserved for patients with persistent symptoms despite conservative care.

    This Clinical Policy Bulletin provides a partial, general description of plan or program benefits and is intended to assist in administering benefits; it does not constitute a contract or guarantee coverage. The bulletin may be updated and is subject to change, and treating providers remain responsible for medical advice and treatment decisions.

    Aetna considers bony correction bunionectomy not medically necessary for specific conditions including: foot ulcers secondary to peripheral vascular disease; gangrene of the foot/ankle/lower leg; non‑ambulatory individuals unless the procedure is performed to relieve ulceration due to prominence; open blisters, pressure sores, or skin ulceration overlying the bunion when the bunion is not the cause; poor tissues at the operative site due to excessive scarring or multiple prior incisions; severe vascular insufficiency significantly impairing circulation (e.g., absent foot pulses, ankle/arm ratio <0.6); or when performed solely to improve appearance (cosmetic).

    The policy describes the Simple exostectomy (Silver) procedure as indicated only for selected patients with a relatively small deformity and no degenerative change at the first MTP joint. Typical candidate criteria include an IMA < 12°, an HVA 15–25°, clinical symptoms from a prominent bunion, and prior failure of conservative management.

    CPT, HCPCS and Diagnosis Codes

    Bony Correction Bunionectomy CPT CodesCPTCovered
    28292Correction, hallux valgus (bunion), with or without sesamoidectomy; Keller, McBride or Mayo type procedure.
    28295Correction, hallux valgus (bunionectomy), with sesamoidectomy, when performed; with proximal metatarsal osteotomy, any method.
    28296Correction, hallux valgus (bunion), with or without sesamoidectomy; with metatarsal osteotomy (e.g., Mitchell, Chevron or concentric type procedures).
    28297Correction, hallux valgus (bunion), with or without sesamoidectomy; Lapidus type procedure.
    28298Correction, hallux valgus (bunion), with or without sesamoidectomy; by phalanx osteotomy.
    28299Correction, hallux valgus (bunion), with or without sesamoidectomy; by double osteotomy.
    Bunionette CPT CodesCPTCovered
    28110Ostectomy, partial excision, fifth metatarsal head (bunionette) (separate procedure).
    Cheilectomy CPT CodesCPTCovered
    28289Hallux rigidus correction with cheilectomy, debridement and capsular release of the first metatarsophalangeal joint.
    Arthrodesis CPT CodesCPTCovered
    28750Arthrodesis, great toe; metatarsophalangeal joint.
    Other CPT/HCPCS codes related to CPBmixed
    11055-11057Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus).
    73620Radiologic examination, foot; 2 views.
    73630Radiologic examination, foot; complete, minimum of 3 views.
    J0702Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg.
    J1020Injection, methylprednisolone acetate, 20 mg.
    J1030Injection, methylprednisolone acetate, 40 mg.
    L3000-L3100Foot inserts and arch supports.
    L3201-L3265Orthopedic footwear.
    ICD-10 Codes (covered and not covered groups mixed as listed)ICD-10
    M20.10-M20.12Hallux valgus (acquired).
    M20.20-M20.22Hallux rigidus.
    M21.611-M21.629Bunion.
    E10.51-E10.59Diabetes with circulatory complications (covered when ulcer/infection stems solely from bunion).
    I73.9Peripheral vascular disease, unspecified (listed as not covered for certain indications).
    I96Gangrene (not covered for certain indications).
    HCPCS / J-codes / Orthotic codesHCPCS
    J1020Injection, methylprednisolone acetate, 20 mg
    J1030Injection, methylprednisolone acetate, 40 mg
    J1040Injection, methylprednisolone acetate, 80 mg
    J1094Injection, dexamethasone acetate, 1 mg
    J1100Injection, dexamethasone sodium phosphate, 1 mg
    J1700Injection, hydrocortisone acetate, up to 25 mg
    J1710Injection, hydrocortisone sodium phosphate, up to 50 mg
    J1720Injection, hydrocortisone sodium succinate, up to 100 mg
    J1741Injection, ibuprofen, 100 mg
    J1885Injection, ketorolac tromethamine, per 15 mg
    1–10 of 17
    1/2
    ICD-10 diagnosis codes (covered if selection criteria met)ICD-10Covered
    M19.071-M19.079Primary osteoarthritis ankle and foot [advanced degenerative joint disease]
    M19.171-M19.179Post-traumatic osteoarthritis, ankle and foot
    M20.10-M20.12Hallux valgus (acquired)
    Q72.30-Q72.33Congenital absence of foot and toe(s)
    S93.121+-S93.129+ / S93.141+-S93.149+Dislocation and subluxation of metatarsophalangeal joint
    Z89.421-Z89.429Acquired absence of other toe(s)
    Conservative treatment duration — At least 6 months
    Required duration of conservative managementAt least 6 months of conservative treatment under direction of a healthcare professional (examples: alternative/modified footwear, corticosteroid injections, debridement of hyperkeratotic lesions, oral analgesics/NSAIDs, protective cushions/pads)
    Documentation neededPersistent pain and difficulty walking despite the trial of conservative care; record of interventions tried and treatment dates
    Radiographic requirementWeight-bearing AP and lateral radiographic confirmation as specified in procedure-specific criteria
    HVA for simple bunionectomy — >= 15 degrees
    HVA threshold (simple bunionectomy)>= 15 degrees measured on weight-bearing radiograph with no degenerative MTP changes
    Clinical requirementsPersistent pain and difficulty walking despite >=6 months conservative care; documentation of skeletal maturity
    Contextual noteAn HVA >15° is considered abnormal (Cochrane review) and may precede symptomatic bunion formation
    HVA for bony correction — >= 30 degrees
    HVA threshold (bony correction)>= 30 degrees on most recent weight-bearing X-ray (required alongside IMA >=12°)
    Associated requirementsPersistent symptoms despite >=6 months conservative care and documentation of skeletal maturity
    Severity implicationHVA >30–35° is often associated with pronation and more advanced deformity
    IMA for bony correction — >= 12 degrees
    IMA threshold (bony correction)>= 12 degrees on weight-bearing radiograph (required alongside HVA >=30°)
    Normal referenceIMA upper limit of normal ~8–9° per background discussion
    Clinical contextIMA >=12° corresponds to moderate deformity (Campbell's staging) and supports need for bony correction when symptomatic
    Bunionette radiographic thresholds — IMA >= 10 degrees and MTP angle >= 16 degrees
    IMA threshold (bunionette)IMA >= 10 degrees on radiograph
    MTP angle threshold (bunionette)MTP angle >= 16 degrees on radiograph
    Clinical requirementPersistent pain and difficulty walking despite >=6 months conservative care and documentation of skeletal maturity
    Angle thresholds (IMA / HVA) — descriptive severity bands and representative thresholds
    IMA severity bandsNormal upper limit ~8–9°; Mild <12°; Moderate 12–16°; Severe >16°
    HVA severity bandsNormal upper limit ~15–20°; Mild 21–30°; Moderate 31–40°; Severe >40°
    Clinical applicationModerate-to-severe angular deformities (per above bands) plus symptoms despite conservative care support surgical consideration

    Documentation, Prior Authorization, and Operational Guidance

    Prior Authorization

    Confirm authorization for listed HCPCS/J‑codes

    Prior authorization may be required for certain HCPCS (L-codes for foot inserts/orthopedic footwear) and injectable J‑codes listed in the coding sections when billed in association with bunion procedures. Confirm member-specific authorization requirements and medical necessity review prior to scheduling or performing procedures.

    • Affected HCPCS ranges include L3000–L3100 (foot inserts/arch supports) and L3201–L3265 (orthopedic footwear).
    • Affected J‑code examples include corticosteroid injections and other injectables listed (e.g., J1020, J1030, J3300–J3302, J1094, J1100, J1700–J1720, J1741, J1885, J2920).
    Denial Risk

    Bilateral procedure restriction

    Bilateral bony correction bunionectomy performed at the same operative session is generally not considered medically necessary. Bilateral procedures should only be performed simultaneously when clearly justified by extenuating clinical circumstances and documented in the medical record.

    Denial Risk

    Not medically necessary indications (bony correction)

    Bony correction bunionectomy is considered not medically necessary for a number of specific clinical situations. Do not authorize bony correction when these exclusionary indications are present unless compelling documentation to the contrary is provided.

    • Foot ulcers secondary to peripheral vascular disease.
    • Gangrene of the foot, ankle or lower leg.
    • Non‑ambulatory individuals unless the procedure is performed specifically to relieve ulceration caused by the bunion.
    • Open blisters, pressure sores, or skin ulceration overlying the bunion when the bunion is not the cause of the skin lesion (risk of osteomyelitis).
    • Poor soft tissues at the operative site from excessive scarring or multiple closely placed prior incisions.
    • Severe vascular insufficiency significantly impairing circulation to the foot (e.g., absent foot pulses, intermittent claudication, ankle/arm index < 0.6).
    • Procedures performed solely to improve appearance (cosmetic).
    Documentation Required

    Medical necessity depends on failed conservative therapy and symptomatic deformity

    Medical necessity for bunion surgery depends on documented failed conservative therapy and persistent symptomatic deformity that interferes with walking or causes pain. Ensure the record demonstrates attempts at and failure of nonoperative measures prior to approval of most surgical interventions.

    • Document persistent pain and difficulty walking despite at least six months of conservative management under a healthcare professional’s direction.
    • Conservative therapies should include (but are not limited to): alternative or modified footwear, corticosteroid injections, debridement of hyperkeratotic lesions, foot orthotics (if applicable), oral analgesics/NSAIDs, and protective cushions/pads.
    Documentation Required

    Procedure selection justification

    Evidence cited in the policy highlights differences in outcomes between procedures (for example, higher revision rates after cheilectomy vs decompression osteotomy for early hallux rigidus, and comparable early radiographic correction between MIS chevron/Akin and modified Lapidus in matched patients). Providers should justify the chosen procedure in the record with reference to deformity severity, risk/benefit considerations, and expected outcomes.

    • When multiple valid surgical options exist, document why the selected procedure is preferred for the patient’s specific radiographic and clinical presentation.
    • Include discussion of comparative outcomes (e.g., revision rates, complication profiles, postoperative restrictions) when relevant to justify procedure choice.
    Note

    Continuous wound infiltration outcomes

    Continuous wound infiltration (CWI) with local anesthetics after hallux valgus surgery did not demonstrate reduced early post‑operative pain in randomized trial data and was associated with device‑related complications in the study. CWI is considered investigational in this context — document justification if used and expect review.

    • Randomized trial (Braito et al., 2018) showed no significant reduction in mean or peak pain, no narcotic-sparing benefit, and reported catheter complications and dislocations.
    • CWI is not described as standard postoperative management in major references (e.g., UpToDate review).
    Documentation Required

    Required documentation for medical necessity

    Required documentation to support medical necessity should be present in the chart and available for review. Incomplete records or absent documentation of required elements may lead to denial of authorization or payment.

    • Clinical documentation of persistent pain and functional limitation despite ≥6 months of conservative management.
    • Detailed record of the conservative therapies attempted (see list under conservative first‑line therapy).
    • Documentation of skeletal maturity (or age ≥18 years when applicable).
    • Weight‑bearing radiographic reports and images with specific angle measurements (HVA, IMA) and description of joint degenerative changes where applicable.
    Documentation Required

    Clinical and radiographic documentation

    Support failed conservative management and symptomatic deformity with clinical and radiographic documentation in the record. Radiographic confirmation must include interpretation of weight‑bearing AP and lateral views.

    • For simple bunionectomy: HVA ≥ 15° on weight‑bearing films with no degenerative changes at the MTP joint (per policy criteria).
    • For bony correction: weight‑bearing films demonstrating HVA ≥ 30° and IMA ≥ 12° (or policy-specified thresholds) where required.
    • Radiographic footnote: include report of weight‑bearing AP and lateral views and explicit angle measurements.
    Documentation Required

    Indication documentation for Lapidus

    When a Lapidus (first tarsometatarsal fusion) procedure is performed, document the clinical indications that support its use. Typical indications include an increased intermetatarsal angle or first‑ray hypermobility.

    • Document an intermetatarsal angle (IMA) > 10° when present and/or objective evidence of first‑ray hypermobility.
    • Correlate radiographic findings with clinical symptoms and explain why a Lapidus is preferred over other osteotomies.
    Step Therapy

    Conservative first‑line therapy

    Conservative, nonoperative measures are the first‑line therapy for bunion deformities and should be exhausted and documented before most surgical interventions are authorized.

    • Conservative measures include: shoe modifications (well‑fitting, low‑heeled shoes with roomy toe box), protective pads/cushions, orthotic inserts where appropriate, NSAIDs/oral analgesics, corticosteroid injections, and debridement of hyperkeratotic lesions.
    • A trial of conservative therapies for at least six months is expected prior to most surgeries; shorter trials may be acceptable only if urgent complications (e.g., ulceration, infection) exist.
    Note

    No denial triggers explicitly listed here

    No explicit administrative denial triggers beyond the clinical coverage criteria are listed in these callouts. Providers should refer to the full policy, payer rules, and review history for operational details; routine administrative checks (eligibility, benefits, prior authorization status) still apply.

    • Check member benefit coverage and any contractual exclusions (e.g., some orthotics may be contractually excluded).
    • Refer to the policy review history and definitions links for additional operational or administrative guidance.

    Background and Clinical Context

    A bunion (hallux valgus) is a progressive deformity of the first ray characterized by lateral deviation of the great toe, splaying of the forefoot, and a prominent medial eminence. Etiologies include heredity, arthritis, trauma and footwear, and prolonged valgus posture can lead to osteoarthritis of the first MTP joint.

    Surgical options include a simple soft‑tissue bunionectomy (exostectomy) for small, symptomatic bumps without joint degeneration; multiple bony correction procedures (e.g., distal osteotomies such as Chevron, proximal osteotomies, Lapidus-type fusion) when angular deformity and structural abnormalities are present; cheilectomy for painful dorsal osteophytes or early hallux rigidus; and arthrodesis (fusion) for advanced deformity, severe degenerative change, failed prior procedures, or when the second toe is absent.

    Selection of the appropriate procedure depends on clinical symptoms refractory to conservative care, radiographic severity measured by the Hallux Valgus Angle (HVA) and Intermetatarsal Angle (IMA), presence and degree of degenerative changes at the first MTP joint, and patient factors such as skeletal maturity and ambulatory status.

    Definitions and Measurement Thresholds

    Hallux Valgus Angle (HVA) — definition and thresholds
    DefinitionAngle formed by the long axis of the proximal phalanx and the first metatarsal; used to quantify hallux valgus severity on weight-bearing radiographs
    Normal upper limitApproximately 15–20 degrees (upper limit of normal)
    Procedure thresholdsCommonly used surgical thresholds include HVA >=15° for simple bunionectomy and HVA >=30° (with IMA >=12°) for bony correction
    Intermetatarsal Angle (IMA) — definition and thresholds
    DefinitionAngle formed by the long axis of the first and second metatarsals; used to quantify transverse plane deformity of the first ray
    Normal upper limitApproximately 8–9 degrees is usually considered the upper limit of normal
    Procedure thresholdsIMA >=12° is used to indicate bony correction for hallux valgus; IMA >=10° is cited for bunionette and IMA >16° denotes severe deformity
    Hallux valgus (HVA) / Intermetatarsal angle (IMA) — summary comparison of measures
    Measure comparisonHVA measures the angle between the proximal phalanx and first metatarsal; IMA measures the angle between the first and second metatarsals
    Complementary rolesBoth angles are used together to stage deformity (Campbell's stages) and determine need for soft-tissue vs bony corrective procedures
    Typical surgical cut-offsExamples: HVA >=15° (abnormal), HVA >=30° + IMA >=12° (indication for bony correction)
    Hallux rigidus / limitus — definition distinguishing from hallux valgus
    DefinitionProgressive loss of motion at the first MTP joint due to degenerative changes, often with dorsal osteophytosis and joint-space narrowing
    Distinguishing feature from hallux valgusHallux rigidus/limitUs is characterized by loss of motion with little or no angular deformity (alignment often remains normal) and prominent dorsal degenerative changes
    Treatment implicationsCheilectomy is appropriate in earlier stages for painful dorsal spurs; arthrodesis or Keller procedure for advanced disease or failed joint-preserving surgery
    Indication for Lapidus — IMA > 10 degrees or first ray hypermobility
    Indication criteriaLapidus procedure indicated when the intermetatarsal angle between the first and second metatarsals is greater than 10 degrees or when the first ray is hypermobile
    Procedure descriptionThe Lapidus involves arthrodesis of the first tarsometatarsal (metatarsalcuneiform) joint to correct deformity and stabilize the first ray
    Documentation recommendationDocument IMA >10° or first ray hypermobility on evaluation when Lapidus is planned
    Definitions / Glossary — references to definitions and glossary links in policy header
    Where to find definitionsDefinitions and glossary links are provided via the policy header (Definitions link in policy)
    Policy metadataRefer to policy review history and effective/last review dates for context (see Policy History)
    Use in documentationProviders should use these referenced definitions when preparing documentation for medical necessity and prior authorization

    Policy Dates and Revision History

    2023-09-12policy_reviewLatest

    Policy was last reviewed on 09/12/2023.

    2002-06-28effective_date

    Policy effective date established as 06/28/2002.

    2024-07-11next_scheduled_review

    Next scheduled policy review set for 07/11/2024.